PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 13F Portfolio
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC runs PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC and currently holds 13 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $307.79M. Their top holdings are PCVX, ARQT, TRVI, AVLN, MPLT. The top five represent 65.7% of reported portfolio weight. PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC ranks #251 out of 1000 investors tracked by Alpha Score. In the most recent quarter, PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC initiated 1 new position. They added to 2 existing positions. They trimmed 3 positions. Their current best-performing preview position is MPLT with returns of +76.29%.
Portfolio Value
$307.79M
Alpha Score
81.9
#251 of 1000
Holdings
13
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC Current 13F Holdings
Reported holdings from PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC's latest SEC 13F filing, ranked by portfolio weight.
13 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 PCVX VAXCYTE INC | 26.92% | $34.54 | $71.38 | +106.66% | Added +3.87% |
 ARQT ARCUTIS BIOTHERAPEUTICS INC | 10.78% | $12.13 | $26.58 | +119.13% | Trimmed -6.68% |
 TRVI TREVI THERAPEUTICS INC | 10.56% | $8.23 | $13.19 | +60.27% | Added +12.16% |
AV AVLN AVALYN PHARMACEUTICALS INC | 10.34% | $32.92 | $25.76 | -21.75% | New Buy |
 MPLT MAPLIGHT THERAPEUTICS INC | 7.12% | $17.57 | $8.83 | -49.74% | Trimmed -0.00% |
 BIOA BIOAGE LABS INC | 5.20% | $17.91 | $6.34 | -64.60% | Held |
 ZBIO ZENAS BIOPHARMA INC | 4.05% | $15.56 | $27.26 | +75.19% | Trimmed -17.10% |
 RXRX RECURSION PHARMACEUTICALS IN | 0.71% | $6.76 | $4.36 | -35.50% | Held |
Showing 1-10 of 13